| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $46.3B | $51.4B | $51.2B | $46.7B | $44.5B | $37.4B | $39.1B | $36.4B |
| Cost of Revenue | $26.5B | $28.5B | $28.9B | $25.2B | $24.6B | $21.2B | $21.6B | — |
| Gross Profit | $19.8B | $22.9B | $22.3B | $21.5B | $20.0B | $16.2B | $17.5B | $16.0B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $16.1B | $16.6B | $16.4B | $14.8B | $13.0B | $13.1B | $12.7B | $11.5B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $3.2B | $5.7B | $5.1B | $6.0B | $5.7B | $2.5B | $4.0B | $1.9B |
| EPS (Basic) | $2.17 | $3.76 | $3.27 | $3.83 | $3.64 | $1.63 | $2.55 | $1.19 |
| EPS (Diluted) | $2.16 | $3.73 | $3.23 | $3.75 | $3.56 | $1.60 | $2.49 | $1.17 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $36.6B | $38.1B | $37.5B | $40.3B | $37.7B | $31.3B | $23.7B | $22.5B |
| Current Assets | $23.4B | $25.4B | $25.2B | $28.2B | $26.3B | $20.6B | $16.5B | $15.1B |
| Cash & Equivalents | $7.5B | $9.9B | $7.4B | $8.6B | $9.9B | $8.3B | $4.5B | $4.2B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $10.6B | $10.6B | $9.3B | $10.7B | $9.7B | $8.3B | $7.9B | $6.0B |
| Stockholders' Equity | $13.2B | $14.4B | $14.0B | $15.3B | $12.8B | $8.1B | $9.0B | $9.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.7B | $7.4B | $5.8B | $5.2B | $6.7B | $2.5B | $5.9B | $5.0B |
| Investing Cash Flow | $-0.3B | $0.9B | $0.6B | $-1.5B | $-3.8B | $-1.0B | $-0.3B | $0.3B |
| Capital Expenditures | $0.4B | $0.8B | $1.0B | $0.8B | $0.7B | $1.1B | $1.1B | $1.0B |
| Financing Cash Flow | $-5.8B | $-5.9B | $-7.4B | $-4.8B | $-1.5B | $2.5B | $-5.3B | $-4.8B |